ABSTRACT
All Company personnel will use the defmitions of "adverse experience" and "serious adverse experience" found in the protocol and FDA regulations.
For clinically significant lab abnormalities, Company personnel will follow the protocol to determine if such abnormalities meet the definition of an SAE.
